Results 11 to 20 of about 500,777 (259)

Multidrug Efflux Pumps in Bacteria and Efflux Pump Inhibitors

open access: yesPostępy Mikrobiologii - Advancements of Microbiology, 2022
Abstract Antimicrobial resistance is becoming a paramount health concern nowadays. The increasing drug resistance in microbes is due to improper medications or over usage of drugs. Bacteria develop many mechanisms to extrude the antibiotics entering the cell. The most prominent are the efflux pumps (EPs).
Sreekantan Abhirami P.   +3 more
openaire   +2 more sources

marA efflux pump gene expression in Salmonella enteritidis strains treated with Artemisia tournefortiana hydroalcoholic extract and comparison with commercial efflux pump inhibitor, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) [PDF]

open access: yes, 2020
Background: Salmonella enterica subsp. enterica serovar Enteritidis is a food-borne pathogenic bacterium that has recently become resistant to most quinolone antibiotics.
Norouzi, Mehdi   +2 more
core   +1 more source

Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria [PDF]

open access: yes, 2010
Background: Traditional antibiotics are increasingly suffering from the emergence of multidrug resistance amongst pathogenic bacteria leading to a range of novel approaches to control microbial infections being investigated as potential alternative ...
Han Haley   +47 more
core   +2 more sources

Flavonoids as Inhibitors of Bacterial Efflux Pumps [PDF]

open access: yesMolecules, 2021
Flavonoids are widely occurring secondary plant constituents, and are abundant in vegetable and fruit diets as well as herbal medicines. Therapeutic treatment options for bacterial infections are limited due to the spread of antimicrobial resistances.
Martin Waditzer, Franz Bucar
openaire   +3 more sources

An alternative physiological role for the EmhABC efflux pump in Pseudomonas fluorescens cLP6a [PDF]

open access: yes, 2011
Background Efflux pumps belonging to the resistance-nodulation-division (RND) superfamily in bacteria are involved in antibiotic resistance and solvent tolerance but have an unknown physiological role.
Foght, J.M., Adebusuyi, A.A.
core   +1 more source

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria [PDF]

open access: yes
In recent years, selenocompounds have gained increasing attention as potential anticancer and antibacterial agents. Several selenoderivatives have been confirmed to act as MDR efflux pump inhibitors, based on their in vitro results against the bacterial ...
Dózsai Dávid   +20 more
core   +2 more sources

Efflux pump effects on Mycobacterium tuberculosis drug resistance

open access: yes, 2023
<p>Resistance and tolerance to antituberculosis drugs have become serious problems in disease treatment. This multi-phase study investigated the contributions of efflux pumps to Mycobacterium tuberculosis drug resistance.
Coban, Ahmet Yilmaz   +2 more
core   +1 more source

Fundamentals of Centrifugal Pump and System Interaction [PDF]

open access: yes, 2011
Short CoursePumps are an integral part of your industry, yet engineers, operators, and maintenance technicians are seldom fully trained to handle the pump problems they encounter daily.
Volk, Michael, Volk, Mike
core   +1 more source

Detection of tetracyclines and efflux pump inhibitors [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 1993
Screening assays for the detection of tetracyclines and inhibitors of tetracycline efflux pumps are described. The tetracycline assay is based on the observation that the tetA(B) gene encoding the efflux pump of transposon Tn10 is induced by tetracycline.
D M, Rothstein   +6 more
openaire   +2 more sources

Mechanisms of RND multidrug efflux pumps [PDF]

open access: yesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
RND (Resistance-Nodulation-Division) family transporters are widespread especially among Gram-negative bacteria, and catalyze the active efflux of many antibiotics and chemotherapeutic agents. They have very large periplasmic domains, and form tripartite complexes with outer membrane channels and periplasmic adaptor proteins.
Hiroshi, Nikaido, Yumiko, Takatsuka
openaire   +2 more sources

Home - About - Disclaimer - Privacy